Backbone alignment modeling of the structure-activity relationships of opioid ligands

Journal of Chemical Information and Modeling

Volumn 51, Issue 5, 2011, Pages 1151-1164

  Wu, Zhijun ^a   Hruby, Victor J ^b  

^a ABC Resources   (United States)

^b University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY;

ALIGNMENT CONCEPT; MEDICINAL CHEMISTRY; PEPTIDE BACKBONES; PHARMACOPHORES; POTENTIAL BINDING; STANDING PROBLEMS; STRUCTURE ACTIVITY RELATIONSHIPS;

LIGANDS;

LEUCINE ENKEPHALIN; LIGAND; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE PEPTIDE; OPIATE RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; MOLECULAR MIMICRY; STRUCTURE ACTIVITY RELATION;

ANALGESICS, OPIOID; ENKEPHALIN, LEUCINE; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; MORPHINE; OPIOID PEPTIDES; RECEPTORS, OPIOID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79960213315     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci2000852     Document Type: Article

References (48)

1. Dhawan, B. N.; Cesselin, F.; Raghubir, R.; Reisine, T.; Bradley, P. B.; Portoghese, P. S.; Hamon, M. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 1996, 48 (4), 567-592. (Pubitemid 27023821)
2. Janecka, A.; Fichna, J.; Janecki, T. Opioid receptors and their ligands. Curr. Top. Med. Chem. 2004, 4(1), 1-17. (Pubitemid 38842558)
3. Hughes, J.; Smith, T.; Morgan, B.; Fothergill, L. Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci. 1975, 16 (12), 1753-1758.
4. Chavkin, C.; Goldstein, A. Specific receptor for the opioid peptide dynorphin: structure-activity relationships. Proc. Natl. Acad. Sci. U.S.A. 1981, 78 (10), 6543-6547. (Pubitemid 12208179)
5. Hruby, V. J.; Porreca, F.; Yamamura, H. I.; Tollin, G.; Agnes, R. S.; Lee, Y. S.; Cai, M.; Alves, I.; Cowell, S.; Varga, E.; Davis, P.; Salamon, Z.; Roeske, W.; Vanderah, T.; Lai, J. New paradigms and tools in drug design for pain and addiction. AAPS J. 2006, 8 (3), E450-460. (Pubitemid 44120911)
6. Eguchi, M. Recent advances in selective opioid receptor agonists and antagonists. Med. Res. Rev. 2004, 24 (2), 182-212. (Pubitemid 38230679)
7. Gentilucci, L.; Tolomelli, A. Recent advances in the investigation of the bioactive conformation of peptides active at the micro-opioid receptor. conformational analysis of endomorphins. Curr. Top. Med. Chem. 2004, 4 (1), 105-121. (Pubitemid 38842562)
8. Kaczor, A.; Matosiuk, D. Non-peptide opioid receptor ligands -recent advances. Part I - agonists. Curr. Med. Chem. 2002, 9 (17), 1567-1589.
9. Trescot, A. M.; Datta, S.; Lee, M.; Hansen, H. Opioid pharmacology. Pain Physician 2008, 11 (2 Suppl), S133-153. (Pubitemid 351682083)
10. Kane, B. E.; Svensson, B.; Ferguson, D. M. Molecular recognition of opioid receptor ligands. AAPS J. 2006, 8 (1), E126-137.
11. Gorin, F. A.; Marshall, G., R. Proposal for the biologically active conformation of opiates and enkephalin. Proc. Natl. Acad. Sci. U.S.A. 1977, 74 (11), 5179-5183. (Pubitemid 8239071)
12. Smith, D.; Griffin, J. F. Conformation of [Leu5]enkephalin from X-ray diffraction: features important for recognition at opiate receptor. Science 1978, 199 (4334), 1214-1216. (Pubitemid 8311128)
13. Zhorov, B. S.; Ananthanarayanan, V. S. Similarity of Ca(2+)-bound conformations of morphine and Met-enkephalin: a computational study. FEBS Lett. 1994, 354 (2), 131-134.
14. Shenderovich, M. D.; Liao, S.; Qian, X.; Hruby, V. J. A three-dimensional model of the δ-opioid pharmacophore: comparative molecular modeling of peptide and nonpeptide ligands. Biopolymers 2000, 53 (7), 565-580. (Pubitemid 30230409)
15. Aubry, A.; Birlirakk, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Marraud, M. Relationship of the Crystal and Molecular Structure of Leucine-enkephalin Trihydrate to That of Morphine. J. Chem. Soc., Chem. Commun. 1988, 963-964.
16. Aubry, A.; Birlirakis, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Marraud, M. A crystal molecular conformation of leucine-enkephalin related to the morphine molecule. Biopolymers 1989, 28 (1), 27-40. (Pubitemid 19053994)
17. Deschamps, J. R.; George, C.; Flippen-Anderson, J. L. Structural studies of opioid peptides: a review of recent progress in x-ray diffraction studies. Biopolymers 1996, 40 (1), 121-139.
18. Wiley, R. A.; Rch, D. H. Peptidomimetics derived from natural products. Med. Res. Rev. 1993, 13 (3), 327-384. (Pubitemid 23114518)
19. Portoghese, P. S. An approach to the design of receptor-type-selective non-peptide antagonists of peptidergic receptors: δ opioid antagonists. J. Med. Chem. 1991, 34 (6), 1757-1762.
20. Schwyzer, R.; Moutevelis-Minakakis, P.; Kimura, S.; Gremlich, H. U. Lipid-induced secondary structures and orientations of (Leu5)-enkephalin: helical and crystallographic double-bend conformers revealed by IRATR and molecular modelling. J. Pept. Sci. 1997, 3 (1), 65-81. (Pubitemid 127554132)
21. Deber, C. M.; Behnam, B. A. Role of membrane lipids in peptide hormone function: binding of enkephalins to micelles. Proc. Natl. Acad. Sci. U.S.A. 1984, 81 (1), 61-65. (Pubitemid 14186353)
22. Marcotte, I.; Separovic, F.; Auger, M.; Gagne, S. M. A Multidimensional 1H NMR Investigation of the Conformation of Methionine-Enkephalin in Fast-Tumbling Bicelles. Biophys. J. 2004, 86 (3), 1587-1600. (Pubitemid 38295592)
23. Hruby, V. J.; Gehrig, C. A. Recent developments in the design of receptor specific opioid peptides. Med. Res. Rev. 1989, 9 (3), 343-401. (Pubitemid 19189688)
24. Huang, P.; Kehner, G. B.; Cowan, A.; Liu-Chen, L.-Y. Comparison of Pharmacological Activities of Buprenorphine and Norbuprenorphine: Norbuprenorphine Is a Potent Opioid Agonist. J. Pharmacol. Exp. Ther. 2001, 297 (2), 688-695. (Pubitemid 32378001)
25. Portoghese, P. S.; Moe, S. T.; Takemori, A. E. A selective δ 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for δ 1 opioid receptor agonists and antagonists. J. Med. Chem. 1993, 36 (17), 2572-2574. (Pubitemid 23270809)
26. Toll, L.; Berzetei-Gurske, I. P.; Polgar, W. E.; Brandt, S. R.; Adapa, I. D.; Rodriguez, L.; Schwartz, R. W.; Haggart, D.; O'Brien, A.; White, A.; Kennedy, J. M.; Craymer, K.; Farrington, L.; Auh, J. S. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. NIDA Res. Monogr. 1998, 178 440-466.
27. Cox, B. M.; Borsodi, A.; Calo, G. IUPHAR Opioid receptors, 2011. IUPHAR Database; Institutional Union of Basic and Clinical Pharmacology: Kansas City, KS; http://www.iuphar-db.org/DATA-BASE/FamilyMenuForward?familyId=50. Accessed March 27, 2011.
28. Knapp, RJ.; Santoro, G.; DeLeon, I. A.; Lee, K. B.; Edsall, S.A.; Waite, S.; Malatynska, E.; Varga, E.; Calderon, S. N.; Rice, K. C.; Rothman, R. B.; Porreca, F.; Roeske, W. R.; Yamamura, H. I. Structure-activity relationships for SNC80 and related compounds at cloned human δ and μ opioid receptors. J. Pharmacol. Exp. Ther. 1996, 277 (3), 1284-1291. (Pubitemid 27167138)
29. Liao, S.; Alfaro-Lopez, J.; Shenderovich, M. D.; Hosohata, K.; Lin, J.; Li, X.; Stropova, D.; Davis, P.; Jernigan, K. A.; Porreca, F.; Yamamura, H. I.; Hruby, V.J. De Novo Design, Synthesis, and Biological Activities of High-Affinity and Selective Non-Peptide Agonists of the (5-Opioid Receptor. J. Med. Chem. 1998, 41 (24), 4767-4776. (Pubitemid 28530453)
30. Thomas, J. B.; Atkinson, R. N.; Herault, X. M.; Rothman, R. B.; Mascarella, S. W.; Dersch, C. M.; Xu, H.; Horel, R. B.; Carroll, F. I. Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the δ opioid receptor. Bioorg. Med. Chem. Lett. 1999, 9 (23), 3347-3350.
31. Eguchi, M.; Shen, R. Y.; Shea, J. P.; Lee, M. S.; Kahn, M. Design, synthesis, and evaluation of opioid analogues with non-peptidic beta-turn scaffold: enkephalin and endomorphin mimetics. J. Med. Chem. 2002, 45 (7), 1395-1398. (Pubitemid 34246101)
32. Emmerson, P. J.; Liu, M. R.; Woods, J. H.; Medzihradsky, F. Binding affinity and selectivity of opioids at μ, δ and κ receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 1994, 271 (3), 1630-1637. (Pubitemid 24382680)
33. Roth, B. L.; Baner, K.; Westkaemper, R.; Siebert, D.; Rice, K. C.; Steinberg, S.; Ernsberger, P.; Rothman, R. B.; Salvinorin, A a potent naturally occurring nonnitrogenous κ opioid selective agonist. Proc. Natl Acad. Sci. U.S.A. 2002, 99 (18), 11934-11939. (Pubitemid 34994502)
34. Saito, T.; Aoki, F.; Hirai, H.; Inagaki, T.; Matsunaga, Y.; Sakakibara, T.; Sakemi, S.; Suzuki, Y.; Watanabe, S.; Suga, O.; Sujaku, T.; Smogowicz, A. A.; Truesdell, S. J.; Wong, J. W.; Nagahisa, A.; Kojima, Y.; Kojima, N. Erinacine E as a κ opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J. Antibiot. (Tokyo) 1998, 51 (11), 983-990. (Pubitemid 28554166)
35. Hruby, V. J. Designing peptide receptor agonists and antagonists. Nat. Rev. Drug Discovery 2002, 1 (11), 847-858. (Pubitemid 37361580)
36. Janecka, A.; Kruszynski, R. Conformationally restricted peptides as tools in opioid receptor studies. Curr. Med. Chem. 2005, 12 (4), 471-481. (Pubitemid 40305633)
37. Shreder, K.; Zhang, L.; Dang, T.; Yaksh, T. L.; Umeno, H.; DeHaven, R.; Daubert, J.; Goodman, M. Synthesis and biological activity of a novel methylamine-bridged enkephalin analogue (MABE): a new route to cyclic peptides and peptidomimetics. J. Med. Chem. 1998, 41 (14), 2631-2635. (Pubitemid 28321913)
38. Mosberg, H. I.; Hurst, R.; Hruby, V. J.; Gee, K.; Yamamura, H. I.; Galligan, J. J.; Burks, T. F. Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors. Proc. Natl. Acad. Sci. USA. 1983, 80 (19), 5871-5874. (Pubitemid 14227575)
39. Collins, N.; Flippen-Anderson, J. L.; Haaseth, R. C.; Deschamps, J. R.; George, C.; Kover, K.; Hruby, V. J. Conformational Determinants of Agonist versus Antagonist Properties of [D-Pen2,D-Pen5]Enkephalin (DPDPE) Analogs at Opioid Receptors. Comparison of X-ray Crystallographic Structure, Solution 1H NMR Data, and Molecular Dynamic Simulations of [l-Ala3]DPDPE and [D-Ala3]DPDPE. J. Am. Chem. Soc. 1996, 118 (9), 2143-2152.
40. Flippen-Anderson, J. L.; Hruby, V. J.; Collins, N.; George, C.; Cudney, B. X-ray Structure of [D-Pen2,D-Pen5]enkephalin, a Highly Potent, 5. Opioid Receptor-Selective Compound: Comparisons with Proposed Solution Conformations. J. Am. Chem. Soc. 1994, 116 (17), 7523-7531. (Pubitemid 24291811)
41. Kazmierski, W.; Wire, W. S.; Lui, G. K.; Knapp, R. J.; Shook, J. E.; Burks, T. F.; Yamamura, H. I.; Hruby, V.J. Design and synthesis of somatostatin analogues with topographical properties that lead to highly potent and specific μ opioid receptor antagonists with greatly reduced binding at somatostatin receptors. J. Med. Chem. 1988, 31 (11), 2170-2177.
42. Dolle, R. E.; Michaut, M.; Martinez-Teipel, B.; Seida, P. R.; Ajello, C. W.; Muller, A. L.; DeHaven, R. N.; Carroll, P. J. Nascent structure-activity relationship study of a diastereomeric series of κ opioid receptor antagonists derived from CJ-15, 208. Bioorg. Med. Chem. Lett. 2009, 19 (13), 3647-3650.
43. Zadina, J. E.; Hackler, L.; Ge, L. J.; Kastin, A. J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997, 386 (6624), 499-502. (Pubitemid 27164076)
44. Paterlini, M. G.; Avitabile, F.; Ostrowski, B. G.; Ferguson, D. M.; Portoghese, P. S. Stereochemical requirements for receptor recognition of the μ-opioid peptide endomorphin-1. Biophys. J. 2000, 78 (2), 590-599. (Pubitemid 30211819)
45. Janecka, A.; Fichna, J.; Mirowski, M.; Janecki, T. Structure-activity relationship, conformation and pharmacology studies of mor-phiceptin analogues-selective μ-opioid receptor ligands. Mini Rev. Med. Chem. 2002, 2 (6), 565-572.
46. Schiller, P. W.; Weltrowska, G.; Nguyen, T. M.; Wilkes, B. C.; Chung, N. N; Lemieux, C. TIPP[Ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 1993, 36 (21), 3182-3187. (Pubitemid 23326274)
47. Schiller, P. W.; Nguyen, T. M.; Weltrowska, G.; Wilkes, B. C.; Marsden, B. J.; Lemieux, C.; Chung, N. N. Differential stereochemical requirements of μ vs. Δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly Δ-selective peptide antagonists. Proc. Natl. Acad. Sci. U.S.A. 1992, 89 (24), 11871-11875. (Pubitemid 23004746)
48. Accelrys Discovery Studio Visualizer 2.0; Accelrys Software, Inc.: San Diego, CA, 2007.